Advanced BioHealing, Inc. to Present at 29th Annual J.P. Morgan Healthcare Conference

WESTPORT, Conn., Jan. 5, 2011 /PRNewswire/ -- Advanced BioHealing, Inc. (ABH), a leader in commercializing cell-based therapies and delivering on the promise of regenerative medicine, today announced that Kevin Rakin, Chairman and Chief Executive Officer of ABH will present at the 29th Annual J.P. Morgan Healthcare Conference on Tuesday, January 11, 2011 at 4:30 p.m. Pacific Standard Time. The conference will take place at the Westin St. Francis Hotel in San Francisco, Calif.

Also during the J.P. Morgan conference, Dean Tozer, Senior Vice President of ABH will participate in the “Regenerative Medicine State of the Industry Briefing” sponsored by the Alliance for Regenerative Medicine. The briefing will take place on Monday, January 10, 2011 at 10:00 a.m. Pacific Standard Time at the Biotech Showcase 2011 to be held at the Park 55 Hotel in San Francisco.

Kevin C. O’Boyle, Senior Vice President and Chief Financial Officer for ABH will join Mr. Rakin and Mr. Tozer in San Francisco next week.

About Advanced BioHealing, Inc.

Advanced BioHealing develops and commercializes living cell-based therapies that repair damaged human tissue and enable the body to heal itself. ABH currently manufactures and markets Dermagraft®, a bio-engineered skin substitute that assists in restoring damaged tissue and supports the body’s natural healing process. Dermagraft is FDA approved to treat diabetic foot ulcers and is the focus of an ongoing pivotal trial to assess the product’s safety and efficacy in the promotion of healing venous leg ulcers. A privately held company, Advanced BioHealing maintains its corporate office in Westport, Conn. with additional sites in La Jolla, Calif. and Nashville, Tenn. To learn more about Advanced BioHealing, please visit the Company’s web site at www.ABH.com.

SOURCE Advanced BioHealing, Inc.